Clinical expression and antigenic profiles of a Plasmodium vivax vaccine candidate: merozoite surface protein 7 (PvMSP-7)

Clinical expression and antigenic profiles of a Plasmodium vivax vaccine candidate: merozoite surface protein 7 (PvMSP-7)

Abstract Background Vivax malaria is the predominant form of malaria outside Africa, affecting about 14 million people worldwide, with about 2.5 billion people exposed. Development of a Plasmodium vivax vaccine is a priority, and merozoite surface protein 7 (MSP-7) has been proposed as a plausible c...

Full description

Bibliographic Details
Main Authors: Chew Weng Cheng, Somchai Jongwutiwes, Chaturong Putaporntip, Andrew P. Jackson
Format: Article
Language:English
Published: BMC 2019-06-01
Series:Malaria Journal
Subjects:
Malaria
Plasmodium vivax
PvMSP-7
Transcriptomics
Antigen
Epitope
Online Access:http://link.springer.com/article/10.1186/s12936-019-2826-7

Internet

http://link.springer.com/article/10.1186/s12936-019-2826-7

Similar Items